These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 178275)

  • 1. In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.
    Grunberg E; Cleeland R; Beskid G; DeLorenzo WF
    Antimicrob Agents Chemother; 1976 Apr; 9(4):589-94. PubMed ID: 178275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
    Angehrn P; Arisawa M
    J Antibiot (Tokyo); 1982 Nov; 35(11):1584-9. PubMed ID: 6298168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
    Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.
    Moore BA; Brammer KW
    Antimicrob Agents Chemother; 1981 Sep; 20(3):327-31. PubMed ID: 6272628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of the 6beta-amidinopenicillanic acid derivative, mecillinam, chemically linked or combined in varying ratios with 6-aminopenicillanic acid derivatives.
    Grunberg E; Cleeland R
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():59-68. PubMed ID: 893248
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
    Baltimore RS; Klein JO; Wilcox C; Finland M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amdinocillin therapy of experimental animal infections.
    Gordin FM; Sande MA
    Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.
    Tybring L; Melchior NH
    Antimicrob Agents Chemother; 1975 Sep; 8(3):271-6. PubMed ID: 170856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins.
    Blackwell CC; Freimer EH; Tuke GC
    Antimicrob Agents Chemother; 1976 Aug; 10(2):288-92. PubMed ID: 984771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
    Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
    Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PS-6 and PS-7, new beta-lactam antibiotics. In vitro and in vivo evaluation.
    Sakamoto M; Shibamoto N; Iguchi H; Okamura K; Hori S; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1980 Oct; 33(10):1138-45. PubMed ID: 7451364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Kuck NA; Petersen PJ; Weiss WJ; Jacobus NV; Testa RT; Tally FP
    J Chemother; 1989 Jul; 1(4 Suppl):105-6. PubMed ID: 16312325
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination of cefsulodin and mecillinam.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.